Physician profile
Stephanie Amber Traylor
NPI 1306227426
$85,873.02
in general payments reported to CMS, 2019-2025
6 companies · $28K in 2025
The $28K reported for 2025 was more than what 98% of Addiction Medicine (Psychiatry & Neurology) providers received nationally (typical 2025 total: $152).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $38.63 · 2020: $15.29 · 2022: $6,796 · 2023: $18K · 2024: $33K · 2025: $28K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $79K · Food and Beverage: $71.64.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $78,951.59 |
| Food and Beverage | $71.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $85,733.25 | 2022-2025 | |
| Alkermes, INC. | $41.63 | 2023 | Vivitrol |
| Allergan, INC. | $41.20 | 2019-2020 | |
| Abbvie INC. | $29.46 | 2022-2023 | Teflaro |
| Braeburn INC. | $14.76 | 2023 | Brixadi |
| Pfizer INC. | $12.72 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephanie Traylor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.